[HTML][HTML] Pharmaceutical significance of Eudragit: A review
The Eudragit® range of polymers, like the versatile acrylic material Plexiglas (introduced in
1933), grew out of Dr. Rohm's deep knowledge of acrylic acid and its derivatives. In the year …
1933), grew out of Dr. Rohm's deep knowledge of acrylic acid and its derivatives. In the year …
[HTML][HTML] A Systematic Overview of Eudragit® Based Copolymer for Smart Healthcare
Eudragit, synthesized by radical polymerization, is used for enteric coating, precise temporal
release, and targeting the entire gastrointestinal system. Evonik Healthcare Germany offers …
release, and targeting the entire gastrointestinal system. Evonik Healthcare Germany offers …
[图书][B] Handbook of encapsulation and controlled release
M Mishra - 2015 - books.google.com
Written at a level comprehensible to non-experts, this handbook covers the current state of
encapsulation and controlled released technologies, presenting the fundamental processes …
encapsulation and controlled released technologies, presenting the fundamental processes …
Advances in oral controlled drug delivery: the role of drug–polymer and interpolymer non-covalent interactions
S De Robertis, MC Bonferoni, L Elviri… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: After more than four decades of intense research, oral controlled drug delivery
systems (DDSs) still represent a topic of major interest for pharmaceutical scientist and …
systems (DDSs) still represent a topic of major interest for pharmaceutical scientist and …
Acrylated Eudragit® E PO as a novel polymeric excipient with enhanced mucoadhesive properties for application in nasal drug delivery
NN Porfiryeva, SF Nasibullin, SG Abdullina… - International journal of …, 2019 - Elsevier
Abstract Eudragit® E PO (EPO) is a terpolymer based on N, N-dimethylaminoethyl
methacrylate with methylmethacrylate and butylmethacrylate, produced by Evonik Industries …
methacrylate with methylmethacrylate and butylmethacrylate, produced by Evonik Industries …
Insights into the mechanisms of chitosan–anionic polymers-based matrix tablets for extended drug release
L Li, L Wang, J Li, S Jiang, Y Wang, X Zhang… - International Journal of …, 2014 - Elsevier
The aim of this study was to investigate drug release mechanisms from physical mixtures of
chitosan–anionic polymers-based matrix tablets and to obtain a comprehensive …
chitosan–anionic polymers-based matrix tablets and to obtain a comprehensive …
Direct electrochemical biosensing in gastrointestinal fluids
V Ruiz-Valdepeñas Montiel, JR Sempionatto… - Analytical and …, 2019 - Springer
Edible electrochemical biosensors with remarkable prolonged resistance to extreme acidic
conditions are described for direct glucose sensing in gastrointestinal (GI) fluids of different …
conditions are described for direct glucose sensing in gastrointestinal (GI) fluids of different …
Synergetic role of hypromellose and methacrylic acid copolymer in the dissolution improvement of amorphous solid dispersions
Synergetic role of polymer blending on dissolution of amorphous solid dispersion was
investigated. Dissolution rates of hypromellose (HPMC) and methacrylic acid copolymer …
investigated. Dissolution rates of hypromellose (HPMC) and methacrylic acid copolymer …
Reactive melt extrusion to improve the dissolution performance and physical stability of naproxen amorphous solid dispersions
X Liu, L Zhou, F Zhang - Molecular pharmaceutics, 2017 - ACS Publications
The purpose of this study was to investigate the reaction between naproxen (NPX) and
meglumine (MEG) at elevated temperature and to study the effect of this reaction on the …
meglumine (MEG) at elevated temperature and to study the effect of this reaction on the …
Taste masking of propranolol hydrochloride by microbeads of EUDRAGIT® E PO obtained with prilling technique for paediatric oral administration
A Lopalco, N Denora, V Laquintana… - International Journal of …, 2020 - Elsevier
The purpose of this study was to develop a new solid paediatric formulation for propranolol
hydrochloride (PR). This drug is used to treat various paediatric diseases, and recently …
hydrochloride (PR). This drug is used to treat various paediatric diseases, and recently …